RELEEV Cold Sore Treatment
- Product NDC
- 63287-419
- 11-digit product format
- 632870419
- Labeler code
- 63287
- Product ID
- 63287-419_4f110f71-5b1b-b9f2-e063-6294a90a2baa
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Benzalkonium Chloride
- Dosage form
- LIQUID
- Route
- TOPICAL
- Labeler
- Merix Pharmaceutical Corp.
- Application
- M003
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2006-06-01
- Substance
- BENZALKONIUM CHLORIDE
- Active strength
- 1.3 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63287-419 | 63287-419-03 | D | Discontinued by firm | 2026-10-23 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63287-419-33 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63287-419-01 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63287-419-03 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63287-419-06 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63287-419-33 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63287-419-01 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63287-419-03 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63287-419-06 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63287-419-33 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63287-419-01 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63287-419-03 | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63287-419-06 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63287-419-33 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63287-419-01 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63287-419-03 | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63287-419-06 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63287-419-33 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63287-419-01 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63287-419-03 | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63287-419-06 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63287-419-33 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63287-419-01 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63287-419-03 | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63287-419-06 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 63287-419-33 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 63287-419-03 | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 63287-419-01 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 63287-419-06 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 63287-419-33 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 63287-419-03 | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 63287-419-01 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 63287-419-06 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 63287-419-33 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 63287-419-03 | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 63287-419-01 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 63287-419-06 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 63287-419-03 | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 63287-419-03 | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 63287-419-03 | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 63287-419-06 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 63287-419-03 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 63287-419-01 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 63287-419-33 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 63287-419-06 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 63287-419-03 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 63287-419-01 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 63287-419-33 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- RELEEV Cold Sore Treatment
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BENZALKONIUM CHLORIDE | 1.3 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| F5UM2KM3W7 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 63287-419-01 | 2025-01-30 | RELEEV 1 day Cold sore Symptom Treatment |
| 63287-419-03 | 2025-01-30 | RELEEV 1 day Cold sore Symptom Treatment |
| 63287-419-06 | 2025-01-30 | RELEEV 1 day Cold sore Symptom Treatment |
| 63287-419-33 | 2025-01-30 | RELEEV 1 day Cold sore Symptom Treatment |
| 63287-419-01 | 2022-07-15 | RELEEV 1 day Cold sore Symptom Treatment |
| 63287-419-03 | 2022-07-15 | RELEEV 1 day Cold sore Symptom Treatment |
| 63287-419-06 | 2022-07-15 | RELEEV 1 day Cold sore Symptom Treatment |
| 63287-419-33 | 2022-07-15 | RELEEV 1 day Cold sore Symptom Treatment |
| 63287-419-01 | 2022-01-28 | RELEEV 1 day Cold sore Symptom Treatment |
| 63287-419-03 | 2022-01-28 | RELEEV 1 day Cold sore Symptom Treatment |
| 63287-419-06 | 2022-01-28 | RELEEV 1 day Cold sore Symptom Treatment |
| 63287-419-33 | 2022-01-28 | RELEEV 1 day Cold sore Symptom Treatment |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63287-419-01 | RELEEV Cold Sore Treatment | 1 in 1 POUCH | LIQUID | 1 | 19 | |
| 63287-419-01 | RELEEV Cold Sore Treatment | 1 in 1 BLISTER PACK | LIQUID | 1 | 19 | |
| 63287-419-03 | RELEEV Cold Sore Treatment | 1 in 1 BLISTER PACK | LIQUID | 1 | 19 | |
| 63287-419-03 | RELEEV Cold Sore Treatment | 3 mL in 1 BOTTLE, DROPPER | LIQUID | 3 | 19 | |
| 63287-419-06 | RELEEV Cold Sore Treatment | 6 mL in 1 BOTTLE, DROPPER | LIQUID | 6 | 19 | |
| 63287-419-06 | RELEEV Cold Sore Treatment | 1 in 1 BLISTER PACK | LIQUID | 1 | 19 | |
| 63287-419-20 | RELEEV Cold Sore Treatment | 1 in 1 CARTON | LIQUID | 1 | 19 | |
| 63287-419-20 | RELEEV Cold Sore Treatment | 60 mL in 1 BOTTLE, SPRAY | LIQUID | 60 | 19 | |
| 63287-419-33 | RELEEV Cold Sore Treatment | 3 mL in 1 BOTTLE, DROPPER | LIQUID | 3 | 19 | |
| 63287-419-33 | RELEEV Cold Sore Treatment | 1 in 1 BLISTER PACK | LIQUID | 1 | 19 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Henry Schein Povidone-Iodine Swabsticks | POVIDONE-IODINE | Henry Schein, Inc. | 5854f241-6cfc-4e5a-ba72-92dd0703f728 | 2023-10-13 | Warnings | M003 |
| DawnMist Alcohol Hand Sanitizer | ALCOHOL | Dukal LLC | a2df96a9-8514-6839-e053-2a95a90a9417 | 2023-10-13 | Warnings | M003 |
| DUKAL STING RELIEF PAD | BENZOCAINE | Dukal LLC | 67c1ddc7-8fde-4431-84cb-f757682d5f3e | 2023-10-13 | Warnings | M003 |
| First Aid Only First Aid/Burn | LIDOCAINE HYDROCHLORIDE, BENZALKONIUM CHLORIDE | Acme United Corporation | 07245b54-b193-178e-e063-6394a90a2581 | 2023-10-09 | Warnings | M003 |
| Hand sanitizer 2oz 2pk original | ETHYL ALCOHOL | Rejoice International Corp. | 06dc1730-216a-8b4d-e063-6294a90a4184 | 2023-10-04 | Warnings | M003 |
| Hand sanitizer 1.8oz with extra clip original | ETHYL ALCOHOL | Zhejiang Guoyao Jingyue Aerosol Co., Ltd. | 06dcf8dc-0831-475e-e063-6394a90a9fef | 2023-10-04 | Warnings | M003 |
| Hand sanitizer 2oz 2pk original | ETHYL ALCOHOL | Zhejiang Guoyao Jingyue Aerosol Co., Ltd. | 06dd2427-097c-b0fa-e063-6294a90a4f82 | 2023-10-04 | Warnings | M003 |
| Hand sanitizer 1.8oz with extra clip original | ETHYL ALCOHOL | Rejoice International Corp. | 06da0cc1-95f2-4f88-e063-6394a90a25ea | 2023-10-03 | Warnings | M003 |
| First Aid Antiseptic Alcohol Pads Isopropyl Alcohol 70 Rite Aid | ISOPROPYL ALCOHOL | Rite Aid Corporation | aa0df5fe-62d1-407d-b8f9-a7fd9473d569 | 2023-10-02 | Warnings | M003 |
| Foaming Instant Hand Sanitizer with Aloe | ETHANOL | MCKESSON MEDICAL-SURGICAL INC. | 5c1f69b7-c8d8-477c-b614-47a3287b0e4c | 2023-06-05 | Warnings | M003 |
| Bactine Max Dry | LIDOCAINE HYDROCHLORIDE | WellSpring Pharmaceutical Corporation | 466404cd-c46a-4944-b1ac-3b3b17f436a1 | 2022-12-27 | Warnings | M003 |
| Povidone-Iodine Pad | POVIDONE-IODINE | Shandong Haiyan Medical Manufacture Co., Ltd. | c9187a07-92d5-15ac-e053-2995a90af4cb | 2022-03-19 | Warnings | M003 |
| Alcohol Prep Pad | ISOPROPYL ALCOHOL | Shandong Haiyan Medical Manufacture Co., Ltd. | 1a117840-22d0-4a88-b1a6-e43162a444ab | 2022-03-19 | Warnings | M003 |
| FIRSTAR BZK Antiseptic Towelette | BENZALKONIUM CHLORIDE | JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD. | 28591a97-9291-48c8-a8e3-c419180331b3 | 2021-07-06 | Warnings | M003 |
| Bactine Max | BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE | WellSpring Pharmaceutical Corporation | 28e8a311-20a4-45a1-8d5d-ca42b101c275 | 2021-02-24 | Warnings | M003 |
| Hand Sanitizer Lemon 2oz | ALCOHOL | Ningbo Rejoice International | b0a4159a-cb07-4ce6-e053-2995a90a76e7 | 2020-10-02 | Warnings | M003 |
| Sanix Alcohol Hand Rub | ALCOHOL | Topiderm, Inc | a4fbb714-4f20-400a-ab98-f1c8807ce6fc | 2020-03-24 | Warnings | M003 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1049254 | benzalkonium chloride 0.13 % Topical Solution | PSN | fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | 19 |
| 1095485 | Releev Cold Sore 0.13 % Topical Solution | PSN | fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | 19 |
| 1095485 | benzalkonium chloride 1.3 MG/ML Topical Solution [Releev Cold Sore] | SBD | fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | 19 |
| 1049254 | benzalkonium chloride 1.3 MG/ML Topical Solution | SCD | fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | 19 |
| 1049254 | benzalkonium chloride 0.13 % Topical Solution | SY | fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | 19 |
| 1095485 | Releev Cold Sore 0.13 % Topical Solution | SY | fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | 19 |
| 1095485 | Releev Cold Sore 1.3 MG/ML Topical Solution | SY | fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | 19 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63287-419-01 | 63287041901 | 1 POUCH in 1 BLISTER PACK (63287-419-01) / 1 BOTTLE, DROPPER in 1 POUCH / 1 mL in 1 BOTTLE, DROPPER | 1 pouch | 2006-06-01 | 0000-00-00 | No | No | Current |
| 63287-419-03 | 63287041903 | 1 BOTTLE, DROPPER in 1 BLISTER PACK (63287-419-03) > 3 mL in 1 BOTTLE, DROPPER | 2006-06-01 | 0000-00-00 | No | No | Current | |
| 63287-419-06 | 63287041906 | 1 BOTTLE, DROPPER in 1 BLISTER PACK (63287-419-06) / 6 mL in 1 BOTTLE, DROPPER | 2006-06-01 | 0000-00-00 | No | No | Current | |
| 63287-419-20 | 63287041920 | 1 BOTTLE, SPRAY in 1 CARTON (63287-419-20) / 60 mL in 1 BOTTLE, SPRAY | 2026-04-10 | No | No | Current | ||
| 63287-419-33 | 63287041933 | 1 BOTTLE, DROPPER in 1 BLISTER PACK (63287-419-33) / 3 mL in 1 BOTTLE, DROPPER | 2018-08-21 | 0000-00-00 | No | No | Current |